Twitter Beğeni Hilesi

So thrilled for John Liu, MD PhD and launching his lab - I can vouch for how awesome he is since our undergrad years (like 10+ years ago now, time flies). Can't wait to see the discoveries his lab will make, and excited to work together again in the coming months!

#PhDone ✅ So many people to thank - grateful to the Department of Medicine at UCLA Health David Geffen School of Medicine at UCLA #STAR Program for this unique opportunity, my committee members (Marco Giovannini, Steven Jonas, Richard Wirz, & Harley Kornblum). It was truly a village that got me through some of the tough times

Grateful to be part of this study group. Learn from our new publication! #NF2 #schwannomatosis Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors | New England Journal of Medicine nejm.org/doi/full/10.10…

I am sad that I can't be at #NFCon24 this year but thankful for PhiOanh "Leia" NghiemPhu, MD's mentorship in this space for our NF/SWN patients and looking forward to continuing to work with her and lean on her expertise.

It is with heartfelt sorrow that we share news of the passing of Dr. Vic Riccardi. His contributions to our community and the field of NF have been immeasurable, and his legacy will continue to inspire us all. Our tribute: ctf.org/news/honoring-… #EndNF

Happy 4th of July - to celebrate, we asked if there is meaningful heterogeneity within somatic NF1 mutant glioblastomas? We think so biorxiv.org/content/10.110… As always, appreciate everyone that made this work possible UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr Neurofibromatosis Therapeutic Acceleration Program Children's Tumor Fdn

Super cool!

Our comparative analysis of #IDHmutant #glioma is finally published in SNO. Years in the making and thankful for the support of AaronYeo Keith Ligon Wenya Linda Bi Mehdi Touat Jen Cotter and all of our co-authors academic.oup.com/neuro-oncology…

Exciting News! Vorasidenib (brand name: Voranigo) has just been approved by the FDA for the treatment of adult and pediatric patients 12 years of age and older with grade 2 astrocytoma or oligodendroglioma with an IDH1 or IDH2 mutation. Read more: braintumor.org/news/exciting-…

Congratulations Anthony Wang, MD on all your hard work to bring this trial to fruition. So heartening to have a promising clinical trial for this rare brain tumor disproportionately impacting the #AYA population. UCLA Neurosurgery 🧠 #BTSM

Congrats! Proud to support Soragni:Lab! The lack of therapies for #cNF stems from the complexity of their cell composition. Dr. Soragni & team developed a high-throughput organoid screening platform that rapidly tests 3D tumor organoids for drug efficacy. Great work! #NF1

The FDA has granted Priority Review to our New Drug Application for our investigational MEK inhibitor for children and adults with #NF1-PN. Our EU Marketing Authorization submission has also been validated by the European Medicines Agency. Learn more: ir.springworkstx.com/news-releases/…

Thrilled to share our latest work, just out in Clinical Cancer Research! Seamless collab between Jack Shern’s lab NCI CCR Pediatric Oncology Branch, Angela Hirbe’s lab WashUOncology + my lab Mayo Clinic Radiation Oncology. Led by 1st authors Taylor Sundby, MD 🧬, J Szymanski & A Pan. Tweetorial coming soon from Taylor! aacrjournals.org/clincancerres/…

Excellent work showing the importance of comprehensive genetic testing in people with schwannomas who do not meet clinical diagnostic criteria for NF2-related schwannomatosis #NF2 #schwannomatosis #genetictesting #variantinterpretation #NWGLH #UoM The North West Genomic Laboratory Hub pubmed.ncbi.nlm.nih.gov/39209702/

Watch this video from Guillermo Chantada, SIOP President, and Rodney Wong, CCI President, to learn more about how you can get involved throughout Gold September. Let's inspire hope and drive change—one action at a time. ✨ #GoldSeptember2024 #ChildhoodCancerChallenges

Very happy to announce our latest paper on pediatric/AYA glioma! 🎉See tutorial from fantastic Gustavo Cruzeiro and Ilon Liu below 👇🏻- I’m so very proud of your resilience and dedication! #endbraincancer Dana-Farber Dana-Farber/Boston Children's Boston Children's

In oncology, we care for children with horrific diseases that occur without cause. Sadly, childhood cancer is a part of life. SCHOOL SHOOTINGS on the other hand aren’t a part of life anywhere else in the world & their very existence is a damning indictment of our country.

How do "benign" meningiomas grow? And can we tell if they're benign using non-invasive tests? Charlotte Eaton from RaleighLab answers both of these question in a collaboration with Danielle Swaney, now online in Nature Communications. UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr UC San Francisco. rdcu.be/dTqVb

Out today in Cancer Cell, Meeki Lad, MPH from my lab shows that skull bone marrow contributes "hybrid neutrophils" to GBM with antigen-presenting capacity allowing an anti-tumoral response. Intracalvarial AMD3100 releases these cells and prolongs survival! sciencedirect.com/science/articl…